InvestorsHub Logo
Followers 52
Posts 9088
Boards Moderated 1
Alias Born 10/25/2007

Re: None

Wednesday, 05/22/2024 9:52:11 AM

Wednesday, May 22, 2024 9:52:11 AM

Post# of 13458
" news coming soon" today announced that three abstracts on mRNA-4157 (V940), an investigational mRNA individualized neoantigen therapy, have been accepted for presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, which will be held May 31 - June 4 in Chicago, IL. mRNA-4157 (V940) is being jointly developed by Moderna and Merck, known as MSD outside of the United States and Canada.

https://investors.modernatx.com/news/news-details/2024/Moderna-Announces-Data-to-be-Presented-at-2024-ASCO-Annual-Meeting/default.aspx
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRNA News